Delivery Order SPE2DB22D2007-SPE2DB25FJ4TF
- Not listed
- The Defense Logistics Agency awarded a $11,087.60 delivery order to AmerisourceBergen Drug Corp for Padcev 30 mg vials, with an ultimate completion date of August 8, 2025. This is a firm fixed-price, non-set-aside contract with performance in Conshohocken, Pennsylvania. The delivery order was awarded on July 18, 2025, as part of AmerisourceBergen's broader engagement with the federal government for pharmaceutical supply. This delivery order falls under AmerisourceBergen's substantial...
- The Defense Logistics Agency awarded a $11,087.70 delivery order to AmerisourceBergen Drug Corp for the supply of Padcev 20 mg vials, with performance to be completed by September 23, 2025. This competitively awarded, firm fixed-price contract is being executed from the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $7,391.80 delivery order for Padcev 20 mg vials under a firm fixed-price contract with an ultimate completion date of August 11, 2025. This is a non-set-aside award, meaning it was competitively awarded without restrictions. The order will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical distributor serving federal medical procurement needs,...
- The Defense Logistics Agency awarded a delivery order valued at $11,087.60 to AmerisourceBergen Drug Corp for the supply of Padcev 30 mg vials. This competitively awarded, firm fixed price contract was executed on September 2, 2025, with an ultimate completion date of September 23, 2025. The pharmaceutical distributor will perform the delivery at its corporate office location in Conshohocken, Pennsylvania. As a non-set-aside procurement, this award reflects AmerisourceBergen's continued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for PADCEV 20 mg vials valued at $7,391.80 on August 19, 2025, with completion targeted for September 10, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is...
- AmerisourceBergen Drug Corp was awarded a $27.7K delivery order by the Defense Logistics Agency's Medical Supply Chain to supply 30 mg vials of Padcev, a specialized oncology medication. The contract, executed on September 2, 2025, with completion targeted for September 23, 2025, represents a firm fixed-price, non-set-aside competitive award. Performance will be executed from the contractor's Conshohocken, Pennsylvania location, which serves as the company's corporate headquarters and primary...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply PADCEV 30 MG Vials. The contract has a firm fixed price of $11,087.60 and a performance period ending on July 14, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $9,999.72, is for the delivery of the pharmaceutical product PADCEV 30 MG VIALS. The contract has a firm fixed price pricing type and a completion date of May 21, 2024. This order is placed under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit global pharmaceutical sourcing and distribution company. The order is for PADCEV 20 MG VIALS, a specialty pharmaceutical product, with a completion date of March 14, 2024 and a potential value of $13,318.56. This delivery order is issued under an indefinite delivery contract (IDC) held by...
- The Defense Logistics Agency awarded a $9,735 delivery order to Amerisourcebergen Drug Corporation for 4561499385 PADCEV 30 MG VIALS. The firm fixed price order is being carried out under the Prime Vendor Pharmaceutical program, with performance taking place in Conshohocken, Pennsylvania through August 3, 2023. As a leading distributor of pharmaceuticals and medical supplies to the Department of Defense, Amerisourcebergen will deliver the cancer treatment vials to DLA distribution centers for...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ4TFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $11,087.60 to AmerisourceBergen Drug Corp for Padcev 30 mg vials, with an ultimate completion date of September 29, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical vendor for federal military and veteran healthcare systems, supplying a comprehensive portfolio of medications, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for Padcev—a specialty oncology pharmaceutical—exemplifies the company's role in supporting Defense Health Agency and military healthcare programs through the DLA's global pharmaceutical supply chain. The broader IDC vehicle enables flexible procurement of both brand-name and generic medications to meet the medical needs of military personnel and beneficiaries worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.1k | 9/8/25 |